临床读片者之间代谢肿瘤负荷与病灶糖酵解的可重复性

The Metabolic Tumor Volume (MTV) and Tumor Lesion Glycolysis (TLG) has been shown to be independent prognostic predictors for clinical outcome in Diffuse Large B-cell Lymphoma (DLBCL).

However, definitions of these measurements have not been standardized, leading to many sources of variation, operator evaluation continues to be one major source. In this study, we propose a reader reproducibility study to evaluate computation of TMV (& TLG) metrics based on differences in lesion delineation.

In the first approach, reader manually corrected regional boundaries after automated detection performed across the lesions in a body scan (Reader M using a manual process, or manual). The other reader used a semi-automated method of lesion identification, without any boundary modification (Reader A using a semi- automated process, or auto). Parameters for active lesion were kept the same, derived from standard uptake values (SUVs) over a 41% threshold.

We systematically contrasted MTV & TLG differences between expert readers (Reader M & A).

We find that MTVs computed by Readers M and A were both concordant between them (concordant correlation coefficient of 0. 96) and independently prognostic with a P-value of 0. 0001 and 0. 0002 respectively for overall survival after treatment.

Additionally, we find TLG for these reader approaches showed concordance (CCC of 0. 96) and was prognostic for over -all survival (p 0. 0001 for both).

In conclusion, the semi-automated approach (Reader A) provides acceptable quantification & prognosis of tumor burden (MTV) and TLG in comparison to expert reader assisted measurement (Reader M) on PET/CT scans.